PACAP deficiency aggravates atherosclerosis in ApoE deficient mice. 2019

Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
Department of Medical Cell Biology, Institute for Anatomy and Cell Biology, Medical Faculty, Philipps-University of Marburg, Robert-Koch-Str. 8, 35037 Marburg, Germany.

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) plays an important role in cytoprotection, inflammation and cardiovascular regulation. Thus, we studied the involvement of PACAP in atherogenesis. Differentiated human THP-1 macrophages (MΦ) were stimulated with oxidized low-density lipoproteins (oxLDL) and the influence of PACAP38 treatment on lipid content and TNF release was determined. To test the effect of PACAP deficiency (PACAP-/-) on the development of atherosclerosis under standard chow (SC) or cholesterol-enriched diet (CED) in vivo, PACAP-/- mice were crossbred with ApoE-/- to generate PACAP-/-/ApoE-/- mice. Blood cholesterol and triglyceride levels were quantified. Lumen stenosis in the brachiocephalic trunk, cellularity and amounts of pro-inflammatory as well as autophagy-, apoptosis- and necroptosis-relevant proteins were analysed in atherosclerotic plaques by quantitative immunohistochemistry. In vitro, PACAP38 inhibited oxLDL-induced intracellular lipid storage as well as TNF release in MФ. In vivo, after SC, but not under CED, PACAP-/-/ApoE-/- mice showed an increased lumen stenosis compared to ApoE-/- mice. In atherosclerotic plaques of PACAP-/-/ApoE-/- mice, the immunoreactive areas of TNF+, IL-1β+, autophagic, apoptotic and necroptotic cells were increased. In contrast, the overall cell density was decreased compared to ApoE-/- under SC, while no differences were seen under CED. Similar plasma cholesterol levels were observed in PACAP-/-/ApoE-/- and ApoE-/- mice under the respective feeding regime. Thus, PACAP-/-/ApoE-/- mice represent a novel mouse model of accelerated atherosclerosis where CED is not required. Our data indicate that PACAP acts as an endogenous atheroprotective neuropeptide. Thus, stable PACAP agonists may have potential as anti-atherosclerotic therapeutics. The specific PACAP receptor(s) mediating atheroprotection remain(s) to be identified.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003251 Constriction, Pathologic The condition of an anatomical structure's being constricted beyond normal dimensions. Stenosis,Stricture,Constriction, Pathological,Pathologic Constriction,Constrictions, Pathologic,Pathologic Constrictions,Pathological Constriction,Stenoses,Strictures
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074084 THP-1 Cells A human leukemia monocytic cell line derived from a patient with LEUKEMIA, MONOCYTIC, ACUTE. It is used as a model to study the function of MONOCYTES and MACROPHAGES, their signaling pathways, nutrient and drug transport. THP-1 Cell Line,Cell Line, THP-1,Cell Lines, THP-1,Cell, THP-1,Cells, THP-1,THP 1 Cell Line,THP 1 Cells,THP-1 Cell,THP-1 Cell Lines
D000074085 Mice, Knockout, ApoE Strains of mice that contain genetic disruptions (knockout) of APOLIPOPROTEINS E genes. They are used as models for ATHEROSCLEROSIS research. Apo E Knockout Mice,ApoE Knockout Mice,Knockout Mice, ApoE,Mice, ApoE Knockout
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
October 2006, Arteriosclerosis, thrombosis, and vascular biology,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
September 2011, Journal of lipid research,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
January 2008, Atherosclerosis,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
December 2023, Animal models and experimental medicine,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
April 2015, Circulation research,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
May 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
June 2015, Cardiovascular research,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
June 2001, The Journal of clinical investigation,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
December 2015, Atherosclerosis,
Erik Rasbach, and Paul Splitthoff, and Gabriel A Bonaterra, and Anja Schwarz, and Lilli Mey, and Hans Schwarzbach, and Lee E Eiden, and Eberhard Weihe, and Ralf Kinscherf
September 2019, Acta pharmacologica Sinica,
Copied contents to your clipboard!